Is there a role for α-blockers in ureteral stent related symptoms? A systematic review and meta-analysis

Journal of Urology

Volumn 186, Issue 3, 2011, Pages 928-934

  Yakoubi, Rachid ^c,d   Lemdani, Mohamed ^b   Monga, Manoj ^d   Villers, Arnaud ^a   Koenig, Philippe ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Department of Biomathematics   (France)

^c UNIV LILLE   (France)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

adrenergic alpha antagonists; quality of life; stents; ureter; ureteral obstruction

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; TAMSULOSIN;

DIZZINESS; DRUG EFFICACY; FOLLOW UP; HEADACHE; HUMAN; HYPOTENSION; META ANALYSIS; MORBIDITY; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; URETER OBSTRUCTION; URETER STENT;

EID: 80051549773     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.04.061     Document Type: Article

References (30)

1. P.D. Zimskind, T.R. Fetter, and J.L. Wilkerson Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically J Urol 97 1967 840
2. M.C. Sighinolfi, S. Micali, and S. De Stefani Indwelling ureteral stents and sexual health: a prospective, multivariate analysis J Urol 178 2007 229
3. J. Irani, J. Siquier, and C. Pirs Symptom characteristics and the development of tolerance with time in patients with indwelling double-pigtail ureteric stents BJU Int 84 1999 276
4. H.B. Joshi, A. Stainthorpe, and R.P. MacDonagh Indwelling ureteral stents: evaluation of symptoms, quality of life and utility J Urol 169 2003 1065
5. C.H. Ho, S.C. Chen, and S.D. Chung Determining the appropriate length of a double-pigtail ureteral stent by both stent configurations and related symptoms J Endourol 22 2008 1427
6. R. Damiano, R. Autorino, and M. De Sio Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study J Endourol 22 2008 651
7. R.D. Norris, R.L. Sur, and W.P. Springhart A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort Urology 71 2008 792
8. D.T. Beiko, J.D. Watterson, and B.E. Knudsen Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy J Endourol 18 2004 723
9. M. Gupta, T. Patel, and K. Xavier Prospective randomized evaluation of periureteral botulinum toxin type A injection for ureteral stent pain reduction J Urol 183 2010 598
10. C. Deliveliotis, M. Chrisofos, and E. Gougousis Is there a role for alpha1-blockers in treating Double-J stent-related symptoms? Urology 67 2006 35
11. H.B. Joshi, N. Newns, and A. Stainthorpe Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure J Urol 169 2003 1060
12. A. Dellis, H.B. Joshi, and A.G. Timoney Relief of stent related symptoms: review of engineering and pharmacological solutions J Urol 184 2010 1267
13. D. Moher, A. Liberati, and J. Tetzlaff Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 2009 b2535
14. T.A. Furukawa, C. Barbui, and A. Cipriani Imputing missing standard deviations in meta-analyses can provide accurate results J Clin Epidemiol 59 2006 7
15. N. Wiebe, B. Vandermeer, and R.W. Platt A systematic review identifies a lack of standardization in methods for handling missing variance data J Clin Epidemiol 59 2006 342
16. Review Manager (RevMan), version 5.0 2008 Nordic Cochrane Centre, The Cochrane Collaboration Copenhagen
17. R. Miyaoka, and M. Monga Ureteral stent discomfort: etiology and management Indian J Urol 25 2009 455
18. S.J. Lee, C. Yoo, and C.Y. Oh Stent position is more important than α-blockers or anticholinergics for stent-related lower urinary tract symptoms after ureteroscopic ureterolithotomy: a prospective randomized study Korean J Urol 51 2010 636
19. N. Navanimitkul, and B. Lojanapiwat Efficacy of tamsulosin 0.4 mg/day in relieving Double-J stent-related symptoms: a randomized controlled study J Int Med Res 38 2010 1436
20. S.C. Park, S.W. Jung, and J.W. Lee The effects of tolterodine extended release and alfuzosin for the treatment of Double-J stent-related symptoms J Endourol 23 2009 1913
21. R. Beddingfield, R.N. Pedro, and B. Hinck Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study J Urol 181 2009 170
22. C. Wang, S. Huang, and C. Chang Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to Double-J stent: a prospectively randomized study Urol Res 37 2009 147
23. C. Wang, S. Huang, and C. Chang Effects of tamsulosin on lower urinary tract symptoms due to Double-J stent: a prospective study Urol Int 83 2009 66
24. C. Pricop, C. Ciuta, and D. Mischianu Is there a role for tamsulosin or solifenacin in the management of urinary tract symptoms in patients with Double-J stents? Urology 74 suppl 2009 abstract 74
25. G.N. Kim, J.H. Seo, and Y.J. Seo Effects of tamsulosin and tolterodine on lower urinary tract symptoms developed from ureteral stent: prospective multicenter study J Urol 179 suppl 2008 442 abstract 1273
26. M. Chrisofos, E. Gkougkousis, and A. Skolarikos Alfuzosin vs tamsulosin in treating Double-J stent related morbidity; a prospective comparative study Eur Urol 6 suppl 2007 41 abstract
27. Y. Seo, K. Lee, and K. Kim Effects of alpha-blocker on lower urinary tract symptoms due to ureteral stent: prospective study Eur Urol 6 suppl 2007 268 abstract
28. H.B. Joshi, S.V. Chitale, and M. Nagarajan A prospective randomized single-blind comparison of ureteral stents composed of firm and soft polymer J Urol 174 2005 2303
29. R. Damiano, R. Autorino, and M. De Sio Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study Eur Urol 48 2005 673
30. G. Giannarini, F.X. Keeley Jr, and F. Valent Predictors of morbidity in patients with indwelling ureteric stents: results of a prospective study using the validated Ureteric Stent Symptoms Questionnaire BJU Int 107 2011 648